euro-biotechnology-genomics-congress-2018-tracks

8 / 19

Page 28
Note:
N o v e m b e r 2 6 - 2 7 , 2 0 1 8 | M a d r i d , S p a i n
&
&
BIOTECHNOLOGY
Euro Congress on
GENOMICS AND MOLECULAR BIOLOGY
International Conference on
CANCER SCIENCE AND THERAPY
Global Congress on
Joint Event on
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
Euro Biotechnology 2018 & Genomics Congress 2018 & Cancer Congress 2018 Journal of RNA and Genomics | ISSN: 2591-7781 | Volume 14
Nezar Ahmed Salim, J RNA Genomics 2018, Volume 14
DO NOT RESUSCITATE EXPRESSLY
ALLOWED NATURAL DEATH: A COMMON
ETHICAL DILEMMA AMONG TERMINALLY
ILL CANCER PATIENTS
Nezar Ahmed Salim
Dubai Health Authority, Dubai
Background: Every human being desires a life without suffering and lives his
or her life in best possible quality of life, but when death is looming from a ter-
minal disease and one is lying in bed with machines to maintain organ func-
tions; there comes the dilemma of the choice. However, patients may place
healthcare providers in an ethical dilemma by declining care or not allowing
them to provide treatment; despite that patients have the right to do so.
Aim: This paper examines the ongoing and controversial debate regarding
the ‘Do Not Resuscitate’ (DNR) orders. It discusses the rights of terminally ill
patients who opt to refuse treatment as well as the various legal and moral
ramifications surrounding this particular topic.
Method: This discussion paper is informed by the results of a literature re-
view. A search was conducted using the electronic databases of Cinahl, Med-
line, PubMed, EPSCO and Science Direct for articles published during 1994
to 2015. Twenty articles were found after extensive searching via electronic
databases. There is no ethical approval to this article.
Results: Number of studies supported the DNR order for terminally ill patients
to allow them to pass away in peace. Also CPR in many cases may not end
up with direct clinical benefits as the resuscitation would not be fruitful or
may even lead to complications, which in result will extend suffering without
treating the underlying illness.
Conclusion and Recommendations: DNR should be taken into consideration
especially with patients who have exhausted all other kind of treatment mo-
dalities; where there is multi-organ failure and hope for a cure has been ex-
hausted. ‘DNR’ as a concept, may also appear harsh and unacceptable for
the patient and their loved ones. The use of this term or language plays an
important role. The authors strongly believe that it would be more appropriate
if the wording is changed from “Do Not Resuscitate” to “Allow Natural Death”.
Nezar Ahmed Salim is the In-Service Educator and Nurse
Researcher in Dubai Hospital, United Arab Emirates. He
obtained his Bachelor’s Degree in Nursing from Hashem-
ite University in 2012 and proceeded to Master’s Degree,
Major in Oncology in 2014 in the same university. He
started as a staff nurse in the Medical-Surgical Oncolo-
gy Unit, King Hussain Cancer Center in Amman, Jordan
from 2012-2015. With commitment for excellence and
career growth, he established the Journal Club at King
Hussein Cancer Center and was awarded as a “Cham-
pion Nurse” of Research in the Magnet Program. From
2015-2018, He worked as an Oncology Nurse in Dubai
Hospital. He was eventually promoted to Nurse Re-
searcher and Educator. Throughout his career, Mr Salim
has published 20 researches and articles in different
international nursing journals (Epidemiology, Incidence,
Mortality, Opinion articles and Experimental). The Al-Jali-
la Foundation approved and funded studies grant to
support the cause of the research. He is also a speaker
and organizer of Nursing Conferences on the United Arab
Emirates and International Level. In 2017, he is awarded
by the Government of Dubai for “You’re our Pride”, Re-
search Category as a best Researcher. The Dubai Health
Authority acknowledge him as a “Recognized Staff” for
his dedication and initiative in the practice of Nursing.
Currently, he is a Board Editorial member of 2 Medical
Journals,. As a nurse researcher, he has a Good clinical
Practice Certificate (GCP) which upholds the scientific
quality standards of clinical trials.
BIOGRAPHY